Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of HCP1306 in Primary Hypercholesterolemia
NCT02205606Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jun 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe in hypercholesterolemia, sponsored by Hanmi Pharmaceutical. Started Jun 2014; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02205606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205606.